Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee
1 other identifier
interventional
172
1 country
1
Brief Summary
The purpose of this study is to determine whether complex linear closure vs second intention healing for cutaneous wounds below the knee affects esthetic outcomes (primary outcome). As secondary outcome, the study team plans to look at patient quality of life measures and complications. This will be a prospective, 2-arm, randomized, evaluator-blinded clinical trial. One half of the patients will receive repair by complex linear closure and the other half of the patients will undergo second intention healing. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as the trace-to-tape method, an objective outcome measure for linear postoperative scars. In addition, patients will be provided a validated quality of life survey to complete. Any adverse events will also be recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 12, 2021
CompletedStudy Start
First participant enrolled
January 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
June 3, 2025
May 1, 2025
8.9 years
September 29, 2021
May 31, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
POSAS
The primary outcome is the sum of the average components of the Observer portion of the Patient and Observer Scar Assessment Scale (POSAS). The observer scale of the POSAS consists of six items (vascularity, pigmentation, thickness, relief, pliability and surface area). All items are scored on a scale ranging from 1 ('like normal skin') to 10 ('worst scar imaginable'). The sum of the six items results in a total score of the POSAS observer scale. Categories boxes are added for each item. Furthermore, an overall opinion is scored on a scale ranging from 1 to 10.
3-12 months
Mean Scar Width
Mean scar width will be measured using the trace-to-tape method.
3-12 months
Secondary Outcomes (2)
Occurrence of Complications
3-12 months
Quality of Life Measures (DLQI)
3-12 months
Study Arms (2)
Complex Linear Closure
EXPERIMENTALThe study participant will receive two layers of sutures to close the wound.
Second Intention Healing
EXPERIMENTALThe study participant will not have any sutures placed.
Interventions
At the follow-up visit, two blinded observers will record their scores independently using the physician observer scar assessment score instrument (POSAS).
Eligibility Criteria
You may qualify if:
- years of age or older
- Able to give informed consent themselves
- Patient scheduled for cutaneous surgical procedure below the knee with a lesion excision diameter of at least 1 cm.
- Willing to return for follow up visit
You may not qualify if:
- Incarceration
- Under 18 years of age
- Pregnant Women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Davis, Department of Dermatology
Sacramento, California, 95816, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 12, 2021
Study Start
January 10, 2022
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
June 3, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share